busulfan has been researched along with Deep Vein Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wick, W | 1 |
| Hermisson, M | 1 |
| Kortmann, RD | 1 |
| Küker, WM | 1 |
| Duffner, F | 1 |
| Dichgans, J | 1 |
| Bamberg, M | 1 |
| Weller, M | 1 |
| Randi, ML | 1 |
| Rossi, C | 1 |
| Fabris, F | 1 |
| Girolami, A | 1 |
| Jantunen, R | 1 |
| Juvonen, E | 1 |
| Ikkala, E | 1 |
| Oksanen, K | 1 |
| Anttila, P | 1 |
| Ruutu, T | 1 |
1 trial available for busulfan and Deep Vein Thrombosis
| Article | Year |
|---|---|
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Brain Neoplasms; Bu | 2002 |
2 other studies available for busulfan and Deep Vein Thrombosis
| Article | Year |
|---|---|
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free | 2000 |
The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Platelets; Busulfan; Female; Huma | 2001 |